Digital health check-ins for older adults with acute leukemia
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study tests whether older adults with acute leukemia can use a digital platform to report their symptoms and well-being during follow-up care. It aims to make monitoring easier and more responsive to patients' needs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years or older.
- You have been diagnosed with acute leukemia (myeloid or lymphoid).
- You are receiving follow-up care at the Hematology Service at Hospital Universitario Central de Asturias.
- You can answer questionnaires on your own or with practical help from a caregiver.
- You have access to an internet-enabled device (like a smartphone, tablet, or computer) either personally or through a caregiver.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a digital tool to help doctors keep an eye on patients with chronic myeloid leukemia who have stopped their treatment. If you join, you'll use the tool to share health updates, which might help you stay safely off treatment.
This study is beta-testing a new app designed to reduce healthcare disparities among people admitted to the hospital with suspected acute leukemia. Your feedback could help make the app more helpful for future patients.
This trial studies how screening for social needs (like housing, food, or transportation) and offering early help can improve care for adults with leukemia. It is for patients newly referred to a leukemia clinic.
This study checks how well remote (at-home) symptom check-ins work for people with certain cancers. It may help patients and clinicians spot problems earlier and improve day-to-day care during treatment and beyond.
This trial tests whether using a mobile app to track daily medication and weekly blood tests can help children with acute lymphoblastic leukemia (ALL) continue maintenance therapy safely at home, without needing to stay in the hospital.
This study tests a digital health app to help you manage symptoms and stay connected with your care team while receiving CAR-T therapy as an outpatient. It's designed for people with blood cancers who have a caregiver living with them.
Hear when a new Leukemia Acute Myeloid trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.